Cablivi gets positive results for rare blood clotting disorder
Sanofi’s Cablivi has been linked with a 74% reduction in aTTP-related death in a Phase III trial published by the New England Journal of Medicine.
Read More
Tag: blood clot
HRT tablets associated with higher risk of blood clots
New research suggests that hormone replacement therapy (HRT) tablets are associated with a higher risk of rare but serious blood clots.
Read More
- Talvey accepted for use in Scotland for relapsed and refractory multiple myeloma
- Alzecure enters collaboration and with Lilly for Alzheimer’s project
- Survodutide trial data show targeted visceral and liver fat reductions
- Johnson & Johnson reports phase 2 data showing nipocalimab reduced SLE disease activity
- European approval enables measles protection with CSL’s immunoglobulin Privigen
